Proposal benchmarking on pap and paracetamol production in china

1,447 views

Published on

"Paracetamol, short for para-acetamino phenol, plays an important role in NSAIDs, namely non-steroidal anti-inflammatory drugs. And para-amino phenol (PAP) is the key raw material for paracetamol production.

In 2008, CCM has carried out benchmarking on PAP and paracetamol production in China (the second edition). And after two years, with more attention on environment from government and technological improvement in production, the PAP and paracetamol production has changed much in China.

In this report, CCM will survey Bengbu Bayi (the only PAP producer adopting catalytic hydrogenation of p-nitrophenol technology in China), Taixing Yangtze, Liaoning Shixing (top two PAP producers in terms of capacity adopting iron reduction of p-nitrochlorobenzene technology) to replace PAP producers in last edition (Jiangsu Zhongming, Liaoning Tianbao and Liaoning Jinhua), and add Zhejiang Kangle (the third largest paracetamol producers in China) in paracetamol benchmarking.

In addition, the future of paracetamol, PAP and its upstream industry and the government's support in China will be revealed in this report. CCM will also find out the alternative replacement product for paracetamol, i.e. and the threat product for APAP in the future.

What are the aims of the report?
- Brief introduction to PAP and paracetamol industry in China
- Governmental policies on PAP & paracetamol industry in China
- Introduction to processes for PAP and paracetamol production
- Most popular methods of PAP and paracetamol in China
- Financial analysis of target PAP and paracetamol producers
- Production cost analysis on target PAP and paracetamol producers
- The future of paracetamol, PAP and its upstream industry
- The alternative replacement product for paracetamol, i.e. and the threat product for paracetamol in the future

What will CCM summit to clients?
- Independent and authoritative research report in Word-format with around 100-150 pages
- Over 50 primary tables & 15 figures from a new benchmarking research survey to ensure unrivalled details and most up-to-date info about the market;
- Benchmarking data of all target producers in Excel-format

2. Scopes of investigation

The research of benchmarking on PAP and paracetamol production mainly focuses on China, covering:

Participants:
- Producers
- Raw materials suppliers
- Technology researchers

PAP and paracetamol market
- Production
- Raw material supply
- Technologies
- Forecast

Published in: Education
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,447
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
19
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Proposal benchmarking on pap and paracetamol production in china

  1. 1. Benchmarking on PAP and Paracetamol Production in China Guangzhou CCM Information Science & Technology Co., Ltd. Guangzhou, P. R. China Researched & Prepared by: Proposal The Third Edition November 2010
  2. 2. CCM Data & Primary Intelligence Website: http://www.cnchemicals.com Email: econtact@cnchemicals.com Tel: +86-20-3761 6606 Fax: +86-20-3761 6968 Benchmarking on PAP and Paracetamol Production in China Proposal – The Third Edition November 2010 1. Introduction Paracetamol, short for para-acetamino phenol, plays an important role in NSAIDs, namely non-steroidal anti-inflammatory drugs. And para-amino phenol (PAP) is the key raw material for paracetamol production. In 2008, CCM has carried out benchmarking on PAP and paracetamol production in China (the second edition). And after two years, with more attention on environment from government and technological improvement in production, the PAP and paracetamol production has changed much in China. In this report, CCM will survey Bengbu Bayi (the only PAP producer adopting catalytic hydrogenation of p-nitrophenol technology in China), Taixing Yangtze, Liaoning Shixing (top two PAP producers in terms of capacity adopting iron reduction of p-nitrochlorobenzene technology) to replace PAP producers in last edition (Jiangsu Zhongming, Liaoning Tianbao and Liaoning Jinhua), and add Zhejiang Kangle (the third largest paracetamol producers in China) in paracetamol benchmarking. In addition, the future of paracetamol, PAP and its upstream industry and the government's support in China will be revealed in this report. CCM will also find out the alternative replacement product for paracetamol, i.e. and the threat product for APAP in the future. What are the aims of the report? - Brief introduction to PAP and paracetamol industry in China - Governmental policies on PAP & paracetamol industry in China - Introduction to processes for PAP and paracetamol production - Most popular methods of PAP and paracetamol in China - Financial analysis of target PAP and paracetamol producers - Production cost analysis on target PAP and paracetamol producers - The future of paracetamol, PAP and its upstream industry - The alternative replacement product for paracetamol, i.e. and the threat product for paracetamol in the future
  3. 3. CCM Data & Primary Intelligence Website: http://www.cnchemicals.com Email: econtact@cnchemicals.com Tel: +86-20-3761 6606 Fax: +86-20-3761 6968 What will CCM summit to clients? - Independent and authoritative research report in Word-format with around 100-150 pages - Over 50 primary tables & 15 figures from a new benchmarking research survey to ensure unrivalled details and most up-to-date info about the market; - Benchmarking data of all target producers in Excel-format 2. Scopes of investigation The research of benchmarking on PAP and paracetamol production mainly focuses on China, covering: Participants: - Producers - Raw materials suppliers - Technology researchers PAP and paracetamol market - Production - Raw material supply - Technologies - Forecast
  4. 4. CCMData & Primary Intelligence Website: http://www.cnchemicals.com Email: econtact@cnchemicals.com Tel: +86-20-3761 6606 Fax: +86-20-3761 6968 3. Main content Benchmarking on PAP and Paracetamol Production in China Part Content Remark (compared with last edition) Executive summary Introduction and methodologies I Review of PAP & paracetamol industry I-1 Brief introduction to paracetamol industry in China I-2 Brief introduction to PAP industry in China Update I-3 Governmental policies on PAP & paracetamol industry in China Newly added II Brief introduction to various technologies of PAP and paracetamol in China II-1 Introduction to processes for PAP production II-1.1 Industrialized technologies of PAP - Iron reduction of p-nitrophenol - Catalytic hydrogenation of p-nitrophenol - Catalytic hydrogenation of nitrobenzene II-1.2 Technologies under research - Electrolytic reduction of nitrobenzene - Other findings II-1.3 Comparison among the above four technologies II-2 Introduction to processes for paracetamol production II-2.1 One-step method II-2.2 Two-step method Update, concerning on the latest research in China III Detailed introduction to currently most popular methods of PAP and paracetamol III-1 Technology for PAP III-1.1 Description of production process and theoretical model of raw materials by iron reduction technology III-1.2 Description of production process and theoretical model of raw materials by nitrobenzene catalytic hydrogenation technology III-2 Technology for paracetamol III-2.1 Brief description of production process III-2.2 Flow chart of paracetamol production III-2.3 Theoretical model of raw materials Update IV Estimation on cost and profit of PAP and paracetamol IV-1 In PAP enterprises IV-1.1 Taixing Yangtze (adopting PNCB technology) - Basic situation in Taixing Yangtze - Financial analysis of Taixing Yangtze in 2009 - Estimation on raw material cost - Estimation on manufacturing cost - Estimation on management cost Newly add
  5. 5. CCMData & Primary Intelligence Website: http://www.cnchemicals.com Email: econtact@cnchemicals.com Tel: +86-20-3761 6606 Fax: +86-20-3761 6968 - Estimation on total production cost - Estimation on profit IV-1.2 Liaoning Shixing (adopting PNCB technology) - Basic situation in Liaoning Shixing - Financial analysis of Liaoning Shixing in 2009 - Estimation on raw material cost - Estimation on manufacturing cost - Estimation on management cost - Estimation on total production cost - Estimation on profit Newly add Liaoning Shixing and Liaoning Tianbao are the only two PAP producers in Huludao. IV-1.3 Bengbu Bayi (adopting catalytic hydrogenation of p-nitrophenol technology) - Basic situation in Bengbu Bayi - Financial analysis of Bengbu Bayi in 2009 - Estimation on raw material cost - Estimation on manufacturing cost - Estimation on management cost - Estimation on total production cost - Estimation on profit Newly add IV-1.4 Comparison among above three producers Update IV-2 In paracetamol enterprises IV-2.1 Lu’an Pharm - Basic situation in Lu’an Pharm - Financial analysis of Lu’an Pharm in 2009 - Estimation on raw material cost - Estimation on manufacturing cost - Estimation on management cost - Estimation on total production cost - Estimation on profit Update IV-2.2 Hebei Jiheng - Basic situation in Hebei Jiheng - Actual flowchart in Hebei Jiheng - Financial analysis of Hebei Jiheng in 2009 - Estimation on raw material cost - Estimation on manufacturing cost - Estimation on management cost - Estimation on total production cost - Estimation on profit Update IV-2.3 Zhejiang Kangle - Basic situation in Zhejiang Kangle - Financial analysis of Zhejiang Kangle in 2009 - Estimation on raw material cost - Estimation on manufacturing cost - Estimation on management cost Newly add
  6. 6. CCMData & Primary Intelligence Website: http://www.cnchemicals.com Email: econtact@cnchemicals.com Tel: +86-20-3761 6606 Fax: +86-20-3761 6968 - Estimation on total production cost - Estimation on profit IV-2.4 Comparison among above three producers Update IV-2.5 Nanjing Petrochemical - Basic situation in Nanjing Petrochemical - Process on its paracetamol project Newly add Nanjing Petrochemical doesn’t produce PAP, while it has a paracetamol project, whose detailed information we will need to confirm in this report. V Forecast on PAP & paracetamol industry in China V-1 Forecast on market (Paracetamol & PAP and its upstream industry) V-2 Forecast on technology Update V-3 Alternative replacement products for paracetamol in the future Newly add VI Site visit reports Update Difficulties and solutions Item Difficulty Solution Financial analysis Most producers are not listed companies, and their financial data are not transparent. Meanwhile, since these enterprises also produce other products, financial data can’t completely reflect the PAP or paracetamol production. Financial data will be purchased from third party, and then given the analysis, which is only a reference to benchmark PAP or paracetamol production. PAP producer According to our last visit experience, It is difficult to site visit Liaoning Shixing and Bengbu Bayi, especially for Bengbu Bayi, the only PAP producer adopting catalytic hydrogenation of p-nitrophenol technology in China, who keeps their technology confidential. CCM will endeavor to conduct the site visit on these two producers. Or Lu’an Pharm and Changshu Fengyi will be alternatives for PAP producers. (except Jiangsu Zhongming and Liaoning Tianbao, these two companies rank after above target producers in terms of capacity) Paracetamol producer We can not be sure to site visit all these three producers to get the first-hand data. Tianjin Bofa and Bayi Pharm will be alternatives for paracetamol producer survey. (these two companies rank after above target producers in terms of capacity)
  7. 7. CCMData & Primary Intelligence Website: http://www.cnchemicals.com Email: econtact@cnchemicals.com Tel: +86-20-3761 6606 Fax: +86-20-3761 6968 4. Methodology and sources Periodicals, magazines, journals, Internet, CCM database, other public media or third party database Desk research Producers, raw materials suppliers, associations, industrial experts, etc. Telephone interview Financial data, journals, etc. Financial analysis Quantitative & qualitative analysis, discussion, forecast,etc. Report generationSite visit ValoTracer StepData sources Data to be collected and compiled by CCM will be sourced from: - CCM database (mainly based on ValoTracer) - Published articles from Chinese and foreign periodicals, magazines, journals, third-party database - Telephone interviews with Chinese producers, raw materials suppliers - Site visits on producers - Comments from industrial experts - Information from the Internet - Other public media The research for the report will consist of five stages: Stage 1 Desk research The sources of desk research are various, including Chinese and foreign published magazines, journals, association seminars as well as information from the Internet. A lot of work will go into compilation and analysis of the obtained information. Stage 2 Telephone interviews CCM will carry out extensive telephone interviews in order to survey the actual situation in PAP and paracetamol production. Interviewees will cover: - Key producers
  8. 8. CCMData & Primary Intelligence Website: http://www.cnchemicals.com Email: econtact@cnchemicals.com Tel: +86-20-3761 6606 Fax: +86-20-3761 6968 - Raw material suppliers - Some associations - Researchers and research institutes Stage 3 Financial analysis Financial data in 2009 will be gotten from third-party database suppliers or annual report about listed companies. And then financial analysis will be necessary to further understand financial situation about target producers. Finally, the advantages and disadvantages will be revealed after comparison among the target producers who manufacture the same product. Of course, financial analysis is only a reference to benchmark PAP or paracetamol production since these enterprises not only produce PAP or paracetamol, but also other products. Stage 4 Site visits CCM will carry out site visits and face-to-face interviews with all target producers which will be identified through telephone interviews. The site visits will be presented in the finial report. Stage 5 Report generation Logical analysis and scientific ratiocination will be conducted to generate the report. All the data and findings obtained in the above four stages will be presented in the report clearly. 5. Submission time CCM schedules to finish this report in 2 months after you order.
  9. 9. Copyright © Guangzhou CCM Information Science & Technology Co., Ltd. Any publication, distribution or copying of the content is prohibited. Address: 17th Floor, Huihua Commercial & Trade Building, No.80 Xianlie Zhong Road Guangzhou, 510070, P. R. China Tel: +86-20-37616606 Fax: +86-20-37616968 E-mail: econtact@cnchemicals.com Website: www.cnchemicals.com Related products: Benchmarking on PAP and Paracetamol Production in China (Second edition) The p-Amino Phenol (PAP) Industry in China (Fourth edition) The Paracetamol Industry in China (Fifth edition)

×